Literature DB >> 8062509

Flow cytometric detection of circulating activated platelets and platelet hyper-responsiveness in pre-eclampsia and pregnancy.

S L Janes1, A H Goodall.   

Abstract

1. Platelet activation status and response to stimulation with agonists ex vivo were studied by whole blood flow cytometry in 15 women with pre-eclampsia, 20 age- and gestational-age-matched women who completed a normal pregnancy, and 20 age-matched non-pregnant women. 2. Women with proteinuric pre-eclampsia showed evidence of activated, degranulated platelets in the circulation, with increased platelet-bound fibrinogen, increased expression of the lysosomal granule membrane antigen, CD63, and raised plasma levels of beta-thromboglobulin. 3. CD63 expression and beta-thromboglobulin per platelet were also significantly higher in normal pregnant women than in non-pregnant women, but in these subjects fibrinogen binding was normal. 4. There was good correlation for all subjects in degranulation, measured by CD63 antigen expression, and by plasma beta-thromboglobulin levels corrected for platelet count (r = 0.65; P < 0.01). 5. Platelet responsiveness to ADP in vitro showed a heightened degranulation response (CD63 expression) in normal pregnancy compared with the non-pregnant control group, which was increased further in women with non-proteinuric and proteinuric pre-eclampsia. 6. However, this response was not accompanied by an increased binding of fibrinogen to GPIIb-IIIa. Fibrinogen binding in response to 'weak' agonist stimulation, by low concentrations of ADP or, in a subgroup by adrenaline, was in fact lower in the normal pregnant women than in the non-pregnant women. 7. It is postulated that women at risk of developing pre-eclampsia may have hyper-reactive platelets, primed to undergo release by passage through the abnormal placenta.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8062509     DOI: 10.1042/cs0860731

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  13 in total

Review 1.  Report of the Canadian Hypertension Society Consensus Conference: 2. Nonpharmacologic management and prevention of hypertensive disorders in pregnancy.

Authors:  J M Moutquin; P R Garner; R F Burrows; E Rey; M E Helewa; I R Lange; S W Rabkin
Journal:  CMAJ       Date:  1997-10-01       Impact factor: 8.262

2.  Platelets release pathogenic serotonin and return to circulation after immune complex-mediated sequestration.

Authors:  Nathalie Cloutier; Isabelle Allaeys; Genevieve Marcoux; Kellie R Machlus; Benoit Mailhot; Anne Zufferey; Tania Levesque; Yann Becker; Nicolas Tessandier; Imene Melki; Huiying Zhi; Guy Poirier; Matthew T Rondina; Joseph E Italiano; Louis Flamand; Steven E McKenzie; Francine Cote; Bernhard Nieswandt; Waliul I Khan; Matthew J Flick; Peter J Newman; Steve Lacroix; Paul R Fortin; Eric Boilard
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-31       Impact factor: 11.205

3.  GPIbα reflects the development and progress of the patients with severe preeclampsia.

Authors:  Fu-Ju Wu; Ming-Yang Zheng; Lian-Lian Liu; Dan-Dan Wang; Xiao-Yan Ma
Journal:  Int J Clin Exp Med       Date:  2015-04-15

4.  Case Series of Successful Intravenous Immunoglobulin (IVIG) Treatment in 4 Pregnant Patients with Severe COVID-19-Induced Hypoxia.

Authors:  Matthew Geriak; Dominic McGrosso; David J Gonzalez; Matthew Dehner; George Sakoulas
Journal:  Am J Case Rep       Date:  2022-05-14

5.  Premature labor: a state of platelet activation?

Authors:  Offer Erez; Roberto Romero; Debra Hoppensteadt; Jawed Fareed; Tinnakorn Chaiworapongsa; Juan Pedro Kusanovic; Shali Mazaki-Tovi; Francesca Gotsch; Nandor Gabor Than; Edi Vaisbuch; Chong Jai Kim; Jimmy Espinoza; Pooja Mittal; Neil Hamill; Chia-Ling Nhan-Chang; Moshe Mazor; Sonia Hassan
Journal:  J Perinat Med       Date:  2008       Impact factor: 1.901

6.  Nonovert disseminated intravascular coagulation (DIC) in pregnancy: a new scoring system for the identification of patients at risk for obstetrical hemorrhage requiring blood product transfusion.

Authors:  Ali Alhousseini; Roberto Romero; Neta Benshalom-Tirosh; Dereje Gudicha; Percy Pacora; Dan Tirosh; Doron Kabiri; Lami Yeo; Jecko Thachil; Chaur-Dong Hsu; Sonia S Hassan; Offer Erez
Journal:  J Matern Fetal Neonatal Med       Date:  2020-02-03

7.  Platelet behaviour on von Willebrand Factor changes in pregnancy: Consequences of haemodilution and intrinsic changes in platelet function.

Authors:  Jonathan Cowman; Sieglinde Müllers; Eimear Dunne; Adam Ralph; Antonio J Ricco; Fergal D Malone; Dermot Kenny
Journal:  Sci Rep       Date:  2017-07-25       Impact factor: 4.379

Review 8.  Pre-eclampsia: the Potential of GSNO Reductase Inhibitors.

Authors:  Thomas R Everett; Ian B Wilkinson; Christoph C Lees
Journal:  Curr Hypertens Rep       Date:  2017-03       Impact factor: 5.369

Review 9.  Placental disease and the maternal syndrome of preeclampsia: missing links?

Authors:  Dionne Tannetta; Ian Sargent
Journal:  Curr Hypertens Rep       Date:  2013-12       Impact factor: 5.369

10.  Syncytiotrophoblast Extracellular Vesicles from Pre-Eclampsia Placentas Differentially Affect Platelet Function.

Authors:  Dionne S Tannetta; Kathryn Hunt; Chris I Jones; Naomi Davidson; Carmen H Coxon; David Ferguson; Christopher W Redman; Jonathan M Gibbins; Ian L Sargent; Katherine L Tucker
Journal:  PLoS One       Date:  2015-11-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.